Electric Cigarette a Treatment for Parkinson's Disease Hopes USACIG

USACIG, maker of the "Electric Cigarette" announced they have signed an exclusive agreement with Hop-on to submit it's electronic cigarette technology to the FDA for clinical studies for the prevention and treatment of Parkinson's disease.

Recent studies by the Parkinson's Institute and Clinical Center lead by Maryka Quik, Ph D have indicated intermittent nicotine treatment can reduce medication induced dyskinesias by as much as 50%. USACIG is hoping their electronic cigarette might be the perfect way to deliver nicotine to Parkinson's patients.

Peter Michaels, CEO of Hop-on, the company one usually associates with multi media services, the first disposable cell phone and the licencing of technology like CDMA, GSM and WIFI, says they are excited to be the exclusive agent for FDA submission.

"Studies on nicotine through cigarette use have proven to delay the onset of Parkinson's disease. Nicotine in its natural state removed from cigarettes is safe and non-toxic. USACIG nicotine water technology delivers pure organic and non-toxic nicotine without harmful chemicals. While nicotine has had an image problem due to its association with smoking, there is much excitement about nicotine's potential to prevent and help with a number of medical issues. We are very excited about being USACIG's exclusive agent for FDA submission. USACIG will be working on the funding for clinical studies."

Peter Michaels CEO of Hop-on

USACIG, which manufactures it's cartridges in the US while the electronics are made in China,  has been planning for something like this and has some US doctors on their board "to supervise any medical related issues or opportunities." USACIG is now is in the process of securing funding to start up the clinical trials while Hop-on handles the FDA submission.

Will the Electric Cigarette prove to be a valuable treatment for Parkinson's disease?